No need for strategy in a downturn
It’s been a tough time for the Life Sciences (and other) sectors in 2024. Uncertainty around the future and a slowdown in investment has meant that the sector has stuttered in its growth, and we are in a period of consolidation awaiting (and hoping for) better times. Organizations are downsizing and the job market is not as buoyant as [...]